- Home
- XBIO vs VERO Comparison
XBIO vs VERO Comparison
Compare XBIO & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- VERO
- Stock Information
- Founded
- XBIO N/A
- VERO N/A
- Country
- XBIO United States
- VERO Canada
- Employees
- XBIO N/A
- VERO N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- VERO Medical/Dental Instruments
- Sector
- XBIO Health Care
- VERO Health Care
- Exchange
- XBIO Nasdaq
- VERO Nasdaq
- Market Cap
- XBIO 4.4M
- VERO 4.3M
- IPO Year
- XBIO N/A
- VERO N/A
- Fundamental
- Price
- XBIO $9.83
- VERO $2.57
- Analyst Decision
- XBIO Hold
- VERO
- Analyst Count
- XBIO 1
- VERO 0
- Target Price
- XBIO N/A
- VERO N/A
- AVG Volume (30 Days)
- XBIO 28.4K
- VERO 55.4K
- Earning Date
- XBIO 11-11-2025
- VERO 11-13-2025
- Dividend Yield
- XBIO N/A
- VERO N/A
- EPS Growth
- XBIO N/A
- VERO N/A
- EPS
- XBIO N/A
- VERO N/A
- Revenue
- XBIO $2,446,221.00
- VERO $60,107,000.00
- Revenue This Year
- XBIO $1.99
- VERO N/A
- Revenue Next Year
- XBIO $20.00
- VERO $7.51
- P/E Ratio
- XBIO N/A
- VERO N/A
- Revenue Growth
- XBIO N/A
- VERO N/A
- 52 Week Low
- XBIO $2.20
- VERO $2.10
- 52 Week High
- XBIO $5.27
- VERO $14.50
- Technical
- Relative Strength Index (RSI)
- XBIO 95.26
- VERO 46.71
- Support Level
- XBIO $2.81
- VERO $2.26
- Resistance Level
- XBIO $3.29
- VERO $2.65
- Average True Range (ATR)
- XBIO 0.40
- VERO 0.09
- MACD
- XBIO 0.63
- VERO 0.00
- Stochastic Oscillator
- XBIO 100.00
- VERO 16.44
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.